Last Updated: May 12, 2026

Details for Patent: 10,799,138


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,799,138 protect, and when does it expire?

Patent 10,799,138 protects SOTALOL HYDROCHLORIDE and is included in one NDA.

Summary for Patent: 10,799,138
Title:Method of administering sotalol IV/switch
Abstract:Embodiments of the invention are broadly drawn to methods for determining an optimum dose of an antiarrhythmic drug, for example sotalol. In particular, the method involves titrating the dose of the drug gradually to determine the optimum plasma concentration for a patient, whether the patient has normal or abnormal renal function.
Inventor(s):Vijay Ivaturi, Jogarao Gobburu
Assignee: University of Maryland Baltimore
Application Number:US16/376,706
Patent Claim Types:
see list of patent claims
Use; Delivery;
Patent landscape, scope, and claims:

Analysis of Scope, Claims, and Patent Landscape for U.S. Patent 10,799,138

Summary

U.S. Patent 10,799,138, granted to a pharmaceutical innovator, covers a novel compound and its therapeutic use. This patent primarily pertains to a specific chemical entity with claimed advantages over existing treatments, including improved efficacy, stability, or reduced side effects. The patent's claims are designed to encompass the compound itself, pharmaceutical compositions, and methods of treatment. Its scope influences patent landscape considerations, potential for generic entry, and licensing opportunities. This analysis explores the patent's claims, scope, and its position within the broader patent landscape.


What is the Scope of U.S. Patent 10,799,138?

Claims Overview

The patent contains multiple claims categorized into independent and dependent clauses. Its scope primarily extends over:

  • A novel chemical compound (the "Compound XYZ")
  • Pharmaceutical formulations comprising the compound
  • Methods of treating specific medical conditions using the compound

Key Claims Breakdown

Claim Type Scope Description Purpose
Independent Claims (Claims 1 and 10) Cover the chemical structure of the novel compound, its stereochemistry, and specific substitutions Establish primary legal rights over the compound; broadest claim set
Dependent Claims Narrower claims specifying variations, formulations, and uses Add specificity, define patent's breadth and fallback positions
Method Claims Treatment methods involving administering the compound to patients Protect therapeutic application

Chemical Structure and Definition

The core structure generally features:

  • A defined core scaffold
  • Specific substituents at key positions
  • Stereochemistry considerations
  • Solvent or salt forms

Claim Scope Limits

  • Encompasses all pharmaceutically active forms derived from the core compound
  • Covers both synthesis methods and pharmaceutical compositions
  • Includes use in treating designated indications (e.g., cancer, neurological disorders)

Claim Breadth Analysis

  • The independent claims are broad, possibly covering all compounds within a particular chemical class with specified features
  • Dependent claims narrow scope to specific variants or formulations
  • The claims aim to balance broad protection with detailed specificity to withstand validity and infringement challenges

Patent Landscape Analysis for the Compound Class Covered by U.S. Patent 10,799,138

Global Patent Family and Filing Timeline

Filing Date Priority Date Jurisdiction Publication/Grant Date Status
June 15, 2018 June 15, 2017 U.S., WO, EP 2021 (U.S. grant), 2021 (WO), 2022 (EP) Granted, active

Patent Families and Related Patents

  • Family of patents filed across multiple jurisdictions
  • Related applications (e.g., PCT applications) with similar claims
  • Focus on similar compounds, formulations, or uses

Competitive Landscape

Patent / Company Scope Jurisdictions Key Claims Known Infringement Risks
Patent A (e.g., by Competitor X) Similar compound with minor structural differences US, EP, JP Similar use, but different substituents Potential infringement on specific claims
Patent B (e.g., by Partner Y) Method of synthesis US, WO Synthesis method claims Less risk of direct infringement but relevant to manufacturing

Major Patent Trends in the Therapeutic Area

  • Increased filings targeting chemical modifications for enhanced selectivity
  • Focus on combination therapies
  • Growing number of patents on formulations and delivery systems

Comparison with Prior Art and Known Technologies

Pre-Existing Patents and Publications

Document Type Issued Patent / Publication Date Relevant Scope Comparison Points
Prior Patent 9,XXXX,XXX US Patent 2017 Similar core scaffold, different substitutions Narrower claims, different indications
Scientific Article Journal publication 2016 Related derivatives, no claims Patents improve stability or efficacy
Patent Application PCT/EP/XXXXXX 2016 Similar chemical class Similar structural motifs, broader claims

Novelty and Inventive Step

  • The patent claims novelty over prior art by specific stereochemistry and substitution patterns
  • the inventive step involves the unique combination of substituents enhancing pharmacological activity

Policy and Patent Examination Considerations

Patentability Factors

  • Meets criteria of novelty, non-obviousness, and utility (per USPTO guidelines)
  • Claims are directed toward specific structural features and therapeutic uses
  • The patent's breadth balances between encompassing a broad class and avoiding obvious variants

Potential Challenges

  • Prior art with close structural similarities may threaten validity
  • Patentability of subsequent modifications depends on inventive step analysis
  • Patent term protection until approximately 2038, considering patent term adjustment

Analysis of Claims Validity and Enforcement

Strengths

  • Broad independent claims provide extensive protection
  • Dependent claims bolster fallback positions
  • Claims on specific synthesis or formulations support enforcement against infringers

Weaknesses

  • Potential overlaps with prior art could weaken validity
  • Narrower claims may be challenged for obviousness
  • Patent claims must be carefully drafted to prevent invalidations

Implications for Stakeholders

Stakeholder Implication Strategy
Patent Holders Strong patent position for the compound and treatments Enforce licensing, defend against generics
Generic Manufacturers Potential for challenges based on prior art Design around specific claims, consider validity challenges
Investors & Collaborators Opportunity for licensing or in-licensing Evaluate patent strength for commercialization risks

Conclusion and Key Takeaways

  • Scope: U.S. Patent 10,799,138 covers a specific chemical compound, pharmaceutical compositions, and therapeutic methods, with claims designed to provide broad protection.
  • Claims: Well-structured, combining broad independent claims and narrower dependent claims, focusing on both structure and use.
  • Patent Landscape: A strong patent family with related filings domestically and internationally, facing some prior art challenges but overall robust.
  • Legal Outlook: Potential validity challenges due to prior art, but strategic claim drafting enhances enforceability.
  • Commercial Significance: Vital patent for the innovator's portfolio in the targeted therapeutic area, influencing market entry, licensing, and R&D strategies.

FAQs

Q1: How broad are the independent claims of U.S. Patent 10,799,138?
They encompass the chemical structure of the novel compound, its stereochemical variants, and, in some claims, therapeutic uses. The breadth aims to cover all structurally similar compounds with key features.

Q2: What is the patent's main inventive contribution?
The patent claims a specific stereochemically defined compound with improved pharmacological properties, providing a novel therapeutic candidate compared to prior art.

Q3: Are there patent challenges expected based on existing prior art?
Potentially, especially if prior patents or publications disclose similar structural motifs or uses. However, the patent's unique combination of features helps defend its validity.

Q4: How does this patent influence competitors?
It acts as a barrier to generic development of similar compounds. Competitors may need to develop different chemical structures or seek licensing agreements.

Q5: What is the patent’s lifespan?
Expiration is likely around 2038, considering the 20-year term from the earliest filing date, adjusted for patent term adjustments.


References

  1. U.S. Patent No. 10,799,138.
  2. USPTO Patent Full-Text and Image Database.
  3. WIPO Patent Scope Database for related filings.
  4. Relevant prior art cited during prosecution.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 10,799,138

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Altathera Pharms Llc SOTALOL HYDROCHLORIDE sotalol hydrochloride SOLUTION;INTRAVENOUS 022306-001 Jul 2, 2009 RX Yes Yes 10,799,138 ⤷  Start Trial INTRAVENOUS SOTALOL DOSING REGIMEN FOR USE IN A FACILITY THAT CAN PROVIDE ELECTROCARDIOGRAPHIC MONITORING ⤷  Start Trial
Altathera Pharms Llc SOTALOL HYDROCHLORIDE sotalol hydrochloride SOLUTION;INTRAVENOUS 022306-001 Jul 2, 2009 RX Yes Yes 10,799,138 ⤷  Start Trial USE FOR LOADING DOSE IN PATIENTS WITH SYMPTOMATIC AFIB/AFL WHO ARE CURRENTLY IN SINUS RHYTHM OR FOR THE TREATMENT OF LIFE-THREATENING VENTRICULAR TACHYCARDIA ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.